The effect of a combination therapy with myo-inositol and a combined oral contraceptive pillversusa combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome-Reference-Cited by-同舟云学术

The effect of a combination therapy with myo-inositol and a combined oral contraceptive pillversusa combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome

Published:2011-03-21 Issue:11 Volume:27 Page:920-924
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Minozzi Massimo,Costantino Demetrio,Guaraldi Claudia,Unfer Vittorio

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2011.564685

Reference39 articles.

1. Encuesta sobre práctica clínica en el hiperparatiroidismo primario

2. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

3. The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome

4. The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of metformin, myoinositol and metformin-myoinositol combined treatments for polycystic ovary syndrome;Journal of Turkish Society of Obstetric and Gynecology;2024-06-10

2. Effectiveness, Tolerability and Safety of a Compound Based on D-chiro-inositol + Myo-inositol, Melatonin, Folic Acid, and Vitamin D in Patients with Menstrual Cycle Disorders;Clinical and Experimental Obstetrics & Gynecology;2024-02-04

3. Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future;Expert Opinion on Drug Metabolism & Toxicology;2024-01-22

4. Multiomics in polycystic ovarian syndrome;Biological Insights of Multi-Omics Technologies in Human Diseases;2024

5. Rationale of Insulin-Sensitizing Agents in the Treatment of Functional Bladder Disorders;J BIOL REG HOMEOS AG;2023